Two Sigma Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $88.4K | Sell |
|
|||||
|
2022
Q4 | $422K | Buy |
|
|||||
|
2022
Q3 | $664K | Sell |
|
|||||
|
2022
Q2 | $971K | Sell |
|
|||||
|
2022
Q1 | $2.22M | Sell |
|
|||||
|
2021
Q4 | $4.39M | Buy |
|
|||||
|
2021
Q3 | $2.8M | Buy |
|
|||||
|
2021
Q2 | $1.48M | Buy |
|
|||||
|
2021
Q1 | $850K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $175K | Sell |
|
|||||
|
2020
Q1 | $235K | Sell |
|
|||||
|
2019
Q4 | $1.03M | Sell |
|
|||||
|
2019
Q3 | $469K | Sell |
|
|||||
|
2019
Q2 | $752K | Sell |
|
|||||
|
2019
Q1 | $1.2M | Sell |
|
|||||
|
2018
Q4 | $901K | Buy |
|
|||||
|
2018
Q3 | $1.35M | Buy |
|
|||||
|
2018
Q2 | $601K | Buy |
|